Evidence map›Paper›PMID 33052739›Full record

ArticleAJR. American journal of roentgenology2020

Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.

Bronwyn E Hamilton, Ramon Barajas, Gary M Nesbit, Rongwei Fu, Prakash Ambady, Matthew Taylor, Edward A Neuwelt

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in AJR. American journal of roentgenology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.4field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Bronwyn E HamiltonDepartment of Radiology, Oregon Health & Science University, Portland, OR.
Ramon BarajasDepartment of Radiology, Oregon Health & Science University, Portland, OR.
Gary M NesbitDepartment of Neurointerventional Surgery, Oregon Health & Science University, Portland, OR.
Rongwei FuSchool of Public Health, Oregon Health & Science University, Portland, OR.
Prakash AmbadyDepartment of Neuro-Oncology, Oregon Health & Science University, Portland, OR.
Matthew TaylorDepartment of Hematology-Oncology, Oregon Health & Science University, Portland, OR.
Edward A NeuweltDepartment of Neuro-Oncology, Oregon Health & Science University, Portland, OR.
Oregon Health & Science University · US

Funding

Oregon Clinical and Translational Research Institute KL2 SupplementKL2TR002370 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Catherine Lee Hough · 2017 to 2026
$10.1M
Two Compartment Models to Improve Brain Tumor TherapyR01CA137488 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NEUWELT, EDWARD A. · 2008 to 2019
$7.3M
Opening of the Blood-Brain Barrier to Antitumor AgentsR01CA199111 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI NEUWELT, EDWARD A. · 2016 to 2020
$3.1M
BLRD VA I01 BX003897NCATS NIH HHS KL2 TR002370NCI NIH HHS R01 CA137488NCI NIH HHS R01 CA199111
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Contrast MediaAdultAgedBrain NeoplasmsFemaleFerrosoferric OxideGadoliniumHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective StudiesContrast MediaFerrosoferric OxideGadoliniumbrain metastasescontrast agentsferumoxytol

Identifiers

PMID33052739
PMCPMC8211358
OpenAlexW3093199913

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.